Personalised Cancer Vaccine Reduces Risk by Up to 42% in Trials
A personalised cancer vaccine has shown promising results in clinical trials, reducing the risk of death from skin cancer by up to 42%. This vaccine is tailored to the patient's condition and aims to eliminate tumors at the root. It represents a significant advancement in cancer treatment, especially for lung and skin cancers, offering new hope for patients.
ABP News·




